FeesSafety
Pluang+

KBW names Mark Tweedie as Head of European Investment Banking to boost fintech focus.

Market News
03 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
KBW names Mark Tweedie as Head of European Investment Banking to boost fintech focus.

Keefe, Bruyette & Woods (KBW), a specialist investment bank in financial services and fintech, appointed Mark Tweedie as Managing Director and Head of Investment Banking in Europe. Tweedie, formerly at Citigroup, brings nearly 30 years of experience, especially in fintech, to lead KBW's European growth and strategy from London. This move aims to strengthen KBW's presence in the evolving financial services sector, leveraging Tweedie's expertise to navigate technology and regulatory changes. The appointment comes amid KBW's momentum in Europe, supported by recent key hires.

The appointment of Mark Tweedie as Head of European Investment Banking at KBW provides context for readers following financial sector developments. For readers following financials, here is Pluang's market snapshot as of Nov 03, 2026 17:51 WIB: Of 142 priced Financials-sector US stocks tradable on Pluang, 72 rose and 59 fell today. Notable movers include AVAT (Avalanche Treasury Corporation Class A Common Stock) up 3.67% at USD 0.88 with a typical hold time of 15 days and a Pluang order activity of 29% Sell / 71% Buy, RJF (Raymond James Financial, Inc.) down 3.11% at USD 157.25 with a typical hold time of 77 days, and SLDE (Slide Insurance Holdings Inc. Common Stock) up 2.94% at USD 28.34 with a typical hold time of 11 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
16 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
16 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
16 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App